Nanalysis Announces Third Quarter 2025 Conference Call
Rhea-AI Summary
Pintec (Nasdaq: PT) reported unaudited results for the six months ended June 30, 2025: revenues RMB15.33M (+2.71% YoY), gross profit RMB9.34M (gross margin 60.92%), and net loss RMB4.73M (down 43.26% YoY). Loan facilitation and outstanding balances declined (loans facilitated RMB40.17M, outstanding RMB53.13M).
The company had cash and long-term restricted cash RMB38.90M, negative working capital of RMB403.79M, and an accumulated deficit of RMB2,533.38M. Pintec obtained a US$40M credit line and completed a share-based transaction to consolidate ZIITECH.
Positive
- Revenues up by 2.71% to RMB15.33M
- Gross margin improved to 60.92%
- Net loss reduced by 43.26% to RMB4.73M
- Cash and long-term restricted cash increased to RMB38.90M
- Access to a US$40M credit line at 7% annual rate
Negative
- Negative working capital of RMB403.79M
- Accumulated deficit of RMB2,533.38M
- Loan outstanding balance down 19.11% to RMB53.13M
- Company states substantial doubt about going concern
News Market Reaction – PT
On the day this news was published, PT declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Hosting Call at 4:15 pm ET on Monday, November 24th
Investors interested in participating in the live call can join through Zoom. Details provided below.
Join Zoom Meeting
https://us02web.zoom.us/j/84202060177
Meeting ID: 842 0206 0177
One tap mobile
+16469313860,,84202060177# US
+16694449171,,84202060177# US
The webcast will be archived on the Company's investor relations webpage for at least 90 days.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by a
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
FAQ
What did Pintec (PT) report for revenue in H1 2025?
How did Pintec's net loss change in H1 2025 versus H1 2024?
What liquidity and financing did Pintec secure as of June 30, 2025?
What are the key balance-sheet risks for Pintec (PT) from the release?
How did Pintec's loan portfolio change in H1 2025?
What corporate transaction did Pintec complete after June 30, 2025?
